Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

NOREPINEPHRINE BITARTRATE

FDA · NDA · 2024-12-03

AgencyFDA
Submission typeNDA
Action date2024-12-03
BrandNOREPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE
SponsorLONG GROVE PHARMS
RouteINTRAVENOUS

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T02:34:20.427Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:NOREPINEPHRINE BITARTRATE:2024-12-03

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

NOREPINEPHRINE BITARTRATE — approval | AEaH